<PAGE> 1
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
---------------------
SCHEDULE 13G
(Rule 13d-102)
INFORMATION STATEMENT PURSUANT TO RULES 13d-1 AND 13d-2
UNDER THE SECURITIES EXCHANGE ACT OF 1934
Diatide, Inc.
- --------------------------------------------------------------------------------
(Name of Issuer)
Common Stock, $.001 par value per share
- --------------------------------------------------------------------------------
(Title of Class of Securities)
252842 10 9
----------------------------
(CUSIP Number)
<PAGE> 2
- --------------------------- ---------------------------
CUSIP No. 252842 10 9 13G Page 2 of 9
----------- --- ---
- --------------------------- ---------------------------
SCHEDULE 13G
- --------------------------------------------------------------------------------
1. NAME OF REPORTING PERSONS
S.S. OR I.R.S. IDENTIFICATION NUMBER OF ABOVE PERSONS
Medical Science Partners, L.P.
- --------------------------------------------------------------------------------
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP -
Not Applicable
- --------------------------------------------------------------------------------
3. SEC USE ONLY
- --------------------------------------------------------------------------------
4. CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
- --------------------------------------------------------------------------------
5. SOLE VOTING POWER
0 Shares
NUMBER OF ------------------------------------------------------
SHARES 6. SHARED VOTING POWER
BENEFICIALLY
OWNED BY 936,311 Shares
EACH ------------------------------------------------------
REPORTING 7. SOLE DISPOSITIVE POWER
PERSON
WITH: 0 Shares
------------------------------------------------------
8. SHARED DISPOSITIVE POWER
936,311 Shares
- --------------------------------------------------------------------------------
9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON.
936,311 Shares
- --------------------------------------------------------------------------------
10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES.
Not Applicable
- --------------------------------------------------------------------------------
11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9.
9.2%
- --------------------------------------------------------------------------------
12. TYPE OF REPORTING PERSON.
PN
- --------------------------------------------------------------------------------
<PAGE> 3
- --------------------------- ---------------------------
CUSIP No. 252842 10 9 13G Page 3 of 9
----------- --- ---
- --------------------------- ---------------------------
- --------------------------------------------------------------------------------
1. NAME OF REPORTING PERSONS
S.S. OR I.R.S. IDENTIFICATION NUMBER OF ABOVE PERSONS
Medical Science Ventures, L.P.
- --------------------------------------------------------------------------------
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
Not Applicable
- --------------------------------------------------------------------------------
3. SEC USE ONLY
- --------------------------------------------------------------------------------
4. CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
- --------------------------------------------------------------------------------
5. SOLE VOTING POWER
0 Shares
NUMBER OF ----------------------------------------------------
SHARES 6. SHARED VOTING POWER
BENEFICIALLY
OWNED BY 936,311 Shares
EACH ----------------------------------------------------
REPORTING 7. SOLE DISPOSITIVE POWER
PERSON
WITH: 0 Shares
----------------------------------------------------
8. SHARED DISPOSITIVE POWER
936,311 Shares
- --------------------------------------------------------------------------------
9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON.
936,311 Shares
- --------------------------------------------------------------------------------
10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES.
Not Applicable
- --------------------------------------------------------------------------------
11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9.
9.2%
- --------------------------------------------------------------------------------
12. TYPE OF REPORTING PERSON.
PN
- --------------------------------------------------------------------------------
<PAGE> 4
- --------------------------- ---------------------------
CUSIP No. 252842 10 9 13G Page 4 of 9
----------- --- ---
- --------------------------- ---------------------------
- --------------------------------------------------------------------------------
1. NAME OF REPORTING PERSONS
S.S. OR I.R.S. IDENTIFICATION NUMBER OF ABOVE PERSONS
Andre L. Lamotte
- --------------------------------------------------------------------------------
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
Not Applicable
- --------------------------------------------------------------------------------
3. SEC USE ONLY
- --------------------------------------------------------------------------------
4. CITIZENSHIP OR PLACE OF ORGANIZATION
United States of America
- --------------------------------------------------------------------------------
5. SOLE VOTING POWER
8,840 Shares
NUMBER OF -----------------------------------------------------
SHARES 6. SHARED VOTING POWER
BENEFICIALLY
OWNED BY 1,028,830 Shares
EACH -----------------------------------------------------
REPORTING 7. SOLE DISPOSITIVE POWER
PERSON
WITH: 8,840 Shares
-----------------------------------------------------
8. SHARED DISPOSITIVE POWER
1,028,830 Shares
- --------------------------------------------------------------------------------
9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON.
1,037,670 Shares (Includes 919,089 Shares held by Medical Science
Partners, L.P., the sole general partner of which is Medical Science
Ventures, L.P., of which Mr. Lamotte is a general partner. Also
includes 96,154 Shares held by Medical Science Partners II, L.P. and
13,587 Shares held by Medical Science II Co-Investment L.P., the sole
general partner of each of which is Medical Science Ventures II, L.P.,
of which Mr. Lamotte is a general partner.)
- --------------------------------------------------------------------------------
10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES.
[ ]
- --------------------------------------------------------------------------------
11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9.
10.2%
- --------------------------------------------------------------------------------
12. TYPE OF REPORTING PERSON.
IN
- --------------------------------------------------------------------------------
<PAGE> 5
- --------------------------- ---------------------------
CUSIP No. 252842 10 9 13G Page 5 of 9
----------- --- ---
- --------------------------- ---------------------------
- --------------------------------------------------------------------------------
1. NAME OF REPORTING PERSONS
S.S. OR I.R.S. IDENTIFICATION NUMBER OF ABOVE PERSONS
Joseph F. Lovett
- --------------------------------------------------------------------------------
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
Not Applicable
- --------------------------------------------------------------------------------
3. SEC USE ONLY
- --------------------------------------------------------------------------------
4. CITIZENSHIP OR PLACE OF ORGANIZATION
United States of America
- --------------------------------------------------------------------------------
5. Sole Voting Power
13,382 Shares
NUMBER OF ----------------------------------------------------
SHARES 6. Shared Voting Power
BENEFICIALLY
OWNED BY 1,028,830 Shares
EACH ----------------------------------------------------
REPORTING 7. Sole Dispositive Power
PERSON
WITH: 13,382 Shares
----------------------------------------------------
8. Shared Dispositive Power
1,028,830 Shares
- --------------------------------------------------------------------------------
9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON.
1,042,212 Shares (Includes 919,089 Shares held by Medical Science
Partners, L.P., the sole general partner of which is Medical Science
Ventures, L.P., of which Mr. Lovett is a general partner. Also
includes 96,154 Shares held by Medical Science Partners II, L.P. and
13,587 Shares held by Medical Science II Co-Investment L.P., the sole
general partner of each of which is Medical Science Ventures II, L.P.,
of which Mr. Lovett is a general partner.)
- --------------------------------------------------------------------------------
10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES.
[ ]
- --------------------------------------------------------------------------------
11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9.
10.2%
- --------------------------------------------------------------------------------
12. TYPE OF REPORTING PERSON.
IN
- --------------------------------------------------------------------------------
<PAGE> 6
- --------------------------- ---------------------------
CUSIP No. 252842 10 9 13G Page 6 of 9
----------- --- ---
- --------------------------- ---------------------------
SCHEDULE 13G
Item 1(a). Name of Issuer:
---------------
Diatide, Inc.
Item 1(b). Address of Issuer's Principal Executive Offices:
------------------------------------------------
Nine Delta Drive
Londonderry, New Hampshire 03053
Item 2(a). Name of Person Filing:
----------------------
Andre L. Lamotte for himself and on behalf of:
Medical Science Partners, L.P.
Medical Science Ventures, L.P.
Joseph F. Lovett
Item 2(b). Address of Principal Business Office or, if None, Residence:
------------------------------------------------------------
For each reporting person the business address is:
c/o Medical Science Partners, L.P.
20 William Street
Suite 250
Wellesley, MA 02181
Item 2(c). Citizenship:
------------
Each of Medical Science Partners, L.P. and Medical Science Ventures,
L.P. is organized under the laws of the State of Delaware.
Each of Andre L. Lamotte and Joseph F. Lovett is a citizen of the
United States of America.
<PAGE> 7
- --------------------------- ---------------------------
CUSIP No. 252842 10 9 13G Page 7 of 9
----------- --- ---
- --------------------------- ---------------------------
Item 2(d). Title of Class of Securities:
-----------------------------
Common Stock, $.001 par value per share
Item 2(e). CUSIP Number:
-------------
252842 10 9
Item 3:
Not Applicable
Item 4. Ownership:
(a) Amount Beneficially Owned:
Medical Science Partners, L.P. holds 919,089 Shares. The sole
general partner of Medical Science Partners, L.P. is Medical Science
Ventures, L.P. The general partners of Medical Science Ventures,
L.P., who share voting and investment control over the Shares held
by Medical Science Partners, L.P., are: Andre L. Lamotte and Joseph
F. Lovett. Messrs. Lamotte and Lovett are also general partners of
Medical Science Ventures II, L.P., which is the sole general partner
of each of Medical Science Partners II, L.P. and Medical Science II
Co-Investment L.P. Medical Science Partners II, L.P., Medical
Science II Co-Investment L.P., Mr. Lamotte and Mr. Lovett hold
96,154 Shares, 13,587 Shares, 8,840 Shares and 13,382 Shares,
respectively. Messrs. Lamotte and Lovett disclaim beneficial
ownership of Shares held by Medical Science Partners, L.P., Medical
Science Partners II, L.P. and Medical Science II Co-Investment L.P.
except to the extent of their pecuniary interest therein.
(b) Percent of Class:
10.1%
<PAGE> 8
- --------------------------- ---------------------------
CUSIP No. 252842 10 9 13G Page 8 of 9
----------- --- ---
- --------------------------- ---------------------------
(c) Number of shares as to which such person has:
(i) sole power to vote or to direct the vote:
8,840 Shares;
(ii) shared power to vote or to direct the vote:
1,028,830 Shares;
Item 5. Ownership of Five Percent or Less of a Class:
---------------------------------------------
Not Applicable
Item 6. Ownership of More Than Five Percent on Behalf of Another Person:
----------------------------------------------------------------
Not Applicable
Item 7. Identification and Classification of the Subsidiary which Acquired
------------------------------------------------------------------
the Security Being Reported by the Parent Holding Company:
- ----------------------------------------------------------
Not Applicable
Item 8. Identification and Classification of Members of the Group:
----------------------------------------------------------
Not Applicable
Item 9. Notice of Dissolution of Group:
-------------------------------
Not Applicable
Item 10. Certification:
--------------
By signing below I certify that, to the best of my knowledge and
belief, the securities referred to above were acquired in the
ordinary course of business and were not acquired for the purpose of
and do not have the effect of changing or influencing the control of
the issuer of such securities and were not acquired in connection
with or as a participant in any transaction having such purposes or
effect.
<PAGE> 9
- --------------------------- ---------------------------
CUSIP No. 252842 10 9 13G Page 9 of 9
----------- --- ---
- --------------------------- ---------------------------
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify
that the information set forth in this statement is true, complete and correct.
MEDICAL SCIENCE
PARTNERS, L.P.
By: MEDICAL SCIENCE
VENTURES, L.P.
Date: February 11, 1997 By: /s/ Joseph F. Lovett
--------------------------
Name: Joseph F. Lovett
Title: General Partner
MEDICAL SCIENCE
VENTURES, L.P.
Date: February 11, 1997 By: /s/ Joseph F. Lovett
--------------------------
Name: Joseph F. Lovett
Title: General Partner
Date: February 11, 1997 /s/ Andre L. Lamotte
------------------------------
Andre L. Lamotte
Date: February 11, 1997 /s/ Joseph F. Lovett
------------------------------
Joseph F. Lovett
